LVAD as destination therapy in Belgium: unmet needs and political bias

IBD therapy: new targets and unmet needs.

Inflammatory bowel diseases (IBD) are chronic progressive diseases. Current therapeutic strategies have not significantly altered the natural history of IBD. In the wake of other chronic diseases, such as rheumatoid arthritis, the goal of therapy has now shifted from mere control of symptoms to altering natural history to prevent bowel damage and disability. A 'treat to target' approach using e...

Unmet needs in Iranian cancer patients

    Background: The identification and management of unmet needs is an essential component of health care for the growing cancer patient population. Information about the prevalence of unmet need can help medical service planning/redesigning. Therefore, this study aimed to identify unmet needs in Iranian patients suffering from cancer.    Methods: This cross-sectional ...

Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban

The new generation of non-vitamin K antagonist oral anticoagulants (NOACs) have been welcomed as a convenient alternative to warfarin. Three new oral anticoagulants, dabigatran etexilate, rivaroxaban and apixaban have been approved for the prevention of stroke and systemic embolism (SSE) in patients with atrial fibrillation (AF) and the prevention of venous thromboembolic events (VTEs) in patie...

Unmet Needs in RA: The Role of Anti-TNF Therapy

Unmet needs in rheumatoid arthritis

Until the pathophysiology/etiology of rheumatoid arthritis (RA) is better understood, treatment strategies must focus on disease management. Early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDs) are necessary to reduce early joint damage, functional loss, and mortality. Several clinical trials have now clearly shown that administering appropriate DMARDs early yields ...